Clinical Trials Related to Pancreatic Cancer

Related studies linked through entity extraction aliases.

The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma

Status: NOT_YET_RECRUITING
Phase: N/A

ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

Status: RECRUITING
Phase: NA

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Status: NOT_YET_RECRUITING
Phase: NA

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis

Status: NOT_YET_RECRUITING
Phase: PHASE4

Role of Exosomes in Pancreatic Cancer Progression

Status: RECRUITING
Phase: N/A

Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Status: RECRUITING
Phase: NA

Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions

Status: NOT_YET_RECRUITING
Phase: NA

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Status: AVAILABLE
Phase: N/A

A Study of DM002 in Patients With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients

Status: RECRUITING
Phase: NA

Target-specific immunoPET Imaging of Digestive System Carcinoma

Status: RECRUITING
Phase: NA

Observational Copenhagen Pancreatic Cancer Study

Status: NOT_YET_RECRUITING
Phase: N/A

Spanish Registry of Digestive Tumours RETUD

Status: RECRUITING
Phase: N/A

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Status: RECRUITING
Phase: NA